Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

• Автори: Nestor Szerman (Автор), Ignacio Basurte-Villamor (Автор), Pablo Vega (Автор), Jose Martinez-Raga (Автор), Carlos Parro-Torres (Автор), Julia Cambra Almerge (Автор), Lara Grau-López (Автор), Mario De Matteis (Автор), Francisco Arias (Автор)
• Формат: Книга
• Опубліковано: Adis, Springer Healthcare, 2020-02-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Abstract Aim To evaluate the efficacy and impact of long-acting injectable (LAI) aripiprazole in patients with schizophrenia with a coexisting substance use disorder (SUD). Patients and methods A multicenter, observational, descriptive and retrospective study was conducted in patients with a DSM-5 d...